title: Influenza review and outlook. 2002-2003, with additional considerations for differentiation from inhalation anthrax.
authors.affiliation: Communicable Disease Service New Jersey Department of Health Senior Services Division of Epidemiology, Environmental and Occupational Health, New Jersey, USA.
authors.forename: Robert
authors.initials: R
authors.lastname: Morgan
authors.forename: Christina
authors.initials: C
authors.lastname: Tan
authors.forename: Charles
authors.initials: C
authors.lastname: O'Donnell
authors.forename: Eddy
authors.initials: E
authors.lastname: Bresnitz
mesh_terms: D000881:Anthrax / Q000175:diagnosis; D003428:Cross Infection / Q000517:prevention & control; D003937:Diagnosis, Differential; D006801:Humans; D009980:Influenza A virus / Q000145:classification; D009981:Influenza B virus / Q000145:classification; D007252:Influenza Vaccines / Q000627:therapeutic use*; D007251:Influenza, Human / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control*; D018357:Respiratory Syncytial Virus Infections / Q000175:diagnosis; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
chemical_list: D007252:Influenza Vaccines